These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients. Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, Erdmann E, Schneider CA. Eur J Heart Fail; 2008 Mar; 10(3):315-20. PubMed ID: 18304872 [Abstract] [Full Text] [Related]
3. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R. J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981 [Abstract] [Full Text] [Related]
6. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides? Daly MG, Frampton CM, Troughton RW. J Am Coll Cardiol; 2010 Feb 02; 55(5):451-3. PubMed ID: 20117458 [No Abstract] [Full Text] [Related]
14. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?]. Zieliński T. Kardiol Pol; 2010 Jul 02; 68(7):779-80. PubMed ID: 20648435 [No Abstract] [Full Text] [Related]
15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
16. Serial measurements of plasma B-type natriuretic peptides: what do they tell us? Richards AM. J Am Coll Cardiol; 2008 Sep 16; 52(12):1004-5. PubMed ID: 18786481 [No Abstract] [Full Text] [Related]
17. Natriuretic peptides in heart failure: their role in daily practice. Loboz-Grudzień K, Jaroch J. Cardiol J; 2009 Sep 16; 16(1):1-3. PubMed ID: 19130409 [No Abstract] [Full Text] [Related]
18. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA. Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088 [Abstract] [Full Text] [Related]
19. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm. Bhardwaj A, Januzzi JL. Crit Pathw Cardiol; 2009 Dec 15; 8(4):146-50. PubMed ID: 19952548 [Abstract] [Full Text] [Related]